2018-05-03T20:36:28-05:00 2017-06-30 861065772 DELOITTE TAX LLP 1033 DEMONBREUN STREET SUITE 400 NASHVILLE TN 37203 990 2016-07-01 351044585 AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES INC AMER 9015782000 501 ST JUDE PLACE MEMPHIS TN 38105 JEFFREY T PEARSON CHIEF FINANCIAL OFFICER 9015782000 2018-05-03 1 FRANCIS BEDARD P00752421 6152591800 99.169.247.132 2018-05-03 20:05:19 ED P 2C1F6278B9ACB8DA46D8CE963BCDCB742D5C9078 31FE60C2ABD567A878DE2EF8F6F522EFC42D780D 2016 2021-01-29 14:40:06Z RICHARD C SHADYAC JR 501 ST JUDE PLACE MEMPHIS TN 38105 2311522825 0 X WWW.STJUDE.ORG X 1957 IL TO BUILD AWARENESS AND RAISE FUNDS TO SUPORT ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 43 41 1639 1000000 719985 -963280 1129523176 1314189700 0 0 104109023 157628144 26805048 32174645 1260437247 1503992489 806726696 663714692 0 0 127140895 136864533 7358432 10748191 204076554 240404479 265015178 1181630502 1076342594 78806745 427649895 3491046707 4165731166 66197423 82797217 3424849284 4082933949 X AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC. (ALSAC) WAS FOUNDED IN 1957 AND EXISTS FOR THE SOLE PURPOSE OF RAISING FUNDS AND BUILDING AWARENESS TO SUPPORT THE CURRENT AND FUTURE NEEDS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 0 0 774236364 663714692 20263753 ALSAC IS THE FUNDRAISING AND AWARENESS ORGANIZATION FOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL (ST. JUDE). ALSAC EXISTS SOLELY TO BUILD AWARENESS AND RAISE THE FUNDS NECESSARY TO OPERATE AND MAINTAIN ST. JUDE. BECAUSE OF ALSAC, NO FAMILY EVER RECEIVES A BILL FROM ST. JUDE FOR TREATMENT, TRAVEL, HOUSING OR FOOD - BECAUSE WE BELIEVE ALL A FAMILY SHOULD WORRY ABOUT IS HELPING THEIR CHILD LIVE. IT COSTS NEARLY $1 BILLION TO OPERATE ST. JUDE, AND MORE THAN 75 PERCENT OF ST. JUDE'S BUDGET IS COVERED BY GENEROUS DONORS WHO SUPPORT THE LIFE-SAVING MISSION OF ST. JUDE.(CONTINUED ON SCHEDULE O) 774236364 1 0 0 0 0 0 0 0 0 1 1 1 0 0 1 1 1 1 0 0 1 0 0 1 1 1 0 1 0 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 1 X 1259 59 1 1639 1 1 1 1 AS BD BR VI CA CJ CH EZ DA FR GM GR GK HK HU IN EI IS IT JA MX PE PO RS SF KS SP SW SZ TW UK 0 0 0 1 1 0 0 0 1 0 X 43 41 1 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL CA CT FL GA HI IL KS KY MA MD MI MN MS NH NJ NM NY OH OK OR PA RI SC TN UT WA WI WV X X X JEFFREY T PEARSON 9015782150 501 ST JUDE PLACE MEMPHIS TN 38105 JOYCE ABOUSSIE VOTING DIRECTOR 4.00 4.00 X 0 0 0 SUSAN MACK AQUILLARD MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 MAHIR AWDEH MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH S AYOUB JR ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL J AYOUB ESQ VOTING DIRECTOR 8.00 4.00 X 0 0 0 FREDERICK M AZAR MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JAMES B BARKATE VOTING DIRECTOR 8.00 4.00 X 0 0 0 MARTHA PERINE BEARD VOTING DIRECTOR 4.00 8.00 X 0 0 0 SHERYL BOURISK VOTING DIRECTOR 4.00 4.00 X 0 0 0 ROBERT A BREIT MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 TERRY BURMAN VOTING DIRECTOR 4.00 4.00 X 0 0 0 ANN M DANNER VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH M DEVIVO VOTING DIRECTOR 4.00 4.00 X 0 0 0 FRED P GATTAS III PHARMD VOTING DIRECTOR 4.00 4.00 X 0 0 0 RUTH GAVIRIA VOTING DIRECTOR 4.00 4.00 X 0 0 0 CHRISTOPHER GEORGE MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 JUDY HABIB VOTING DIRECTOR 4.00 4.00 X 0 0 0 GABRIEL GABY HADDAD MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL K HAJAR VOTING DIRECTOR 4.00 4.00 X 0 0 0 CHUCK HAJJAR VOTING DIRECTOR 4.00 4.00 X 0 0 0 FOUAD HAJJAR MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 FREDERICK R HARRIS VOTING DIRECTOR 4.00 4.00 X 0 0 0 FREDERICK R HARRIS JR MD VOTING DIRECTOR 4.00 4.00 X 0 0 0 BRUCE B HOPKINS VOTING DIRECTOR 4.00 4.00 X 0 0 0 J DAVID KARAM II VOTING DIRECTOR 4.00 4.00 X 0 0 0 MICHAEL D MCCOY VOTING DIRECTOR 4.00 4.00 X 0 0 0 ROBERT T MOLINET ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 JAMES NAIFEH JR VOTING DIRECTOR 4.00 4.00 X 0 0 0 RAMZI NUWAYHID VOTING DIRECTOR 4.00 4.00 X 0 0 0 THOMAS PENN III VOTING DIRECTOR 4.00 4.00 X 0 0 0 CAMILLE F SARROUF JR ESQ VOTING DIRECTOR 4.00 8.00 X 0 0 0 JOSEPH C SHAKER VOTING DIRECTOR 4.00 4.00 X 0 0 0 JOSEPH G SHAKER VOTING DIRECTOR 4.00 4.00 X 0 0 0 GEORGE A SIMON II VOTING DIRECTOR 4.00 4.00 X 0 0 0 MICHAEL SIMON VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL J SIMON VOTING DIRECTOR 4.00 4.00 X 0 0 0 TONY THOMAS VOTING DIRECTOR 4.00 4.00 X 0 0 0 RICHARD M UNES VOTING DIRECTOR 4.00 4.00 X 0 0 0 PAUL H WEIN ESQ VOTING DIRECTOR 4.00 4.00 X 0 0 0 THOMAS WERTZ VOTING DIRECTOR 4.00 4.00 X 0 0 0 TAMA ZAYDON VOTING DIRECTOR 4.00 4.00 X 0 0 0 JAMES R DOWNING EX-OFFICIO DIRECTOR 1.00 55.00 X 0 1039955 47189 RICHARD C SHADYAC JR CEO & EX-OFFICIO DIRECTOR 55.00 1.00 X X 772284 0 96359 EMILY S GREER CHIEF ADMIN. OFFICER 55.00 0.00 X 454581 0 88160 JEFFREY T PEARSON CHIEF FINANCIAL OFFICER 55.00 0.00 X 429502 0 87791 EMILY CALLAHAN CHIEF MARKETING OFFICER 55.00 0.00 X 434087 0 80308 ROBERT MACHEN CHIEF INFORMATION OFFICER 55.00 0.00 X 420597 0 76527 ANURAG PANDIT CHIEF INVESTMENT OFFICER 55.00 0.00 X 406398 0 65540 SARA HALL CHIEF LEGAL OFFICER 55.00 0.00 X 380656 0 73595 GEORGE SHADROUI CHIEF STRATEGY OFFICER 55.00 0.00 X 378111 0 69198 3676216 1039955 684667 255 0 1 0 INFOCISION MANAGEMENT CORPORATION 325 SPRINGSIDE DRIVE AKRON OH 443334501 CALL CENTER 5544682 INNERWORKINGS INC 600 W CHICAGO AVENUE CHICAGO IL 60654 PRINT MATERIALS PRODUCTION 4744558 VACO MEMPHIS LLC 5410 MARYLAND WAY 460 BRENTWOOD TN 37027 IT CONTRACT LABOR 4164397 HAVAS EDGE LLC 2386 FARADAY AVE STE 200 CARLSBAD CA 92008 PUBLIC RELATIONS/PURCH. AGENT FOR MEDIA 2385010 F1 CONSULTANCY 8555 154TH AVENUE NE REDMOND WA 98052 EVENT TECHNOLOGY SUPPORT 1925636 46 9338998 8081600 1296769102 16683289 1314189700 22493770 -557672 23051442 349169 0 349169 349169 349169 925759916 1680252 791812320 493474 133947596 1186778 135134374 1186778 133947596 17139341 8081600 5668497 11470844 11470844 27071844 7994869 19076975 19076975 2838833 1561176 1277657 1277657 1503992489 20263753 719985 168819051 X 663714692 663714692 1888496 385429 542524 960543 108087663 22335561 30559326 55192776 7340041 1498397 2062547 3779097 11771919 2392133 3277166 6102620 7776414 1596137 2170985 4009292 1391075 220057 373078 797940 264436 264436 10748191 10748191 12795170 5714731 2595533 4484906 439261 71613 151069 216579 16675439 2883150 11098382 2693907 7039232 1224430 1946145 3868657 7668781 1593828 1404983 4669970 3314904 614872 527930 2172102 11490275 2069197 7268516 2152562 2450879 449622 869877 1131380 CAMPAIGN EXPENSES 87754471 38773660 7175148 41805663 MAILINGS & SHIPPING 81681719 20801610 16961376 43918733 PRINTING & PUBLICATIONS 6471208 1167039 968271 4335898 TELECOMMUNICATIONS 4472375 2639436 1111371 721568 21105953 4090770 6701013 10314170 1076342594 774236364 98029676 204076554 X 115786548 55079954 17621622 43084972 184208650 178285983 21072936 21768125 526178 519821 2055073 1623787 4742600 3597012 209619531 65656566 106463891 143962965 3171977379 3815973473 3491046707 4165731166 31031114 46858623 35166309 35938594 66197423 82797217 X 2486887729 3043957995 64904956 73722532 873056599 965253422 3424849284 4082933949 3491046707 4165731166 427649895 230434770 0 X 0 1 X 1 0 X 851256497 948816088 1028565644 1129523176 1314189700 5272351105 851256497 948816088 1028565644 1129523176 1314189700 5272351105 5272351105 26795864 26681448 25637216 22528839 23051442 124694809 457311 809907 1154757 434311 700774 3557060 34065867 39397254 40875736 38532271 44211185 197082313 5597685287 0.94190 0.93720 X PART II, LINE 10: COLUMN (A): 2012 - TOTAL OF 34,065,867 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 12,143,709 B. GROSS GAMING RECEIPTS: 21,922,158 COLUMN (B): 2013 - TOTAL OF 39,397,254 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 15,425,686 B. GROSS GAMING RECEIPTS: 23,971,568 COLUMN (C): 2014 - TOTAL OF 40,875,736 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 13,672,319 B. GROSS GAMING RECEIPTS: 27,203,417 COLUMN (D): 2015 - TOTAL OF 38,532,271 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 15,414,176 B. GROSS GAMING RECEIPTS: 23,118,095 COLUMN (E): 2016 - TOTAL OF 44,211,185 CONSISTS OF: A. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): 17,139,341 B. GROSS GAMING RECEIPTS: 27,071,844 873056599 12552432 103475245 23830854 965253422 873885134 2341719 -72118 3098136 873056599 915104075 2970640 8222632 52412213 873885134 843843273 1097137 121617552 51453887 915104075 782714653 705311 69209599 8786290 843843273 1.00000 1 0 41663857 41663857 77825940 17355767 60470173 257398 192302 65096 28225290 20018893 8206397 61647046 28089604 33557442 143962965 GLOBAL EQUITY 1475534847 F MARKETABLE ALTERNATIVES 1125519198 F REAL ASSETS 381924095 F PRIVATE EQUITY 453443379 F FIXED INCOME 282977240 F CASH EQUIVALENTS 96574714 F 3815973473 ANNUITY OBLIGATIONS 35938594 35938594 X 1742422128 230434770 230434770 1511987358 -7994869 -7994869 1503992489 1084337463 7994869 7994869 1076342594 0 1076342594 PART V, LINE 4: THE INTENDED USE OF THE ORGANIZATION'S ENDOWMENT FUND IS TO SUPPORT THE CURRENT AND FUTURE NEEDS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. AS IT COSTS ABOUT $1 BILLION PER YEAR TO OPERATE ST. JUDE. AS A CHILDREN'S RESEARCH HOSPITAL, ST. JUDE MUST BE ABLE TO CONDUCT PIONEERING RESEARCH AND PROVIDE LIFESAVING CARE TO PATIENTS REGARDLESS OF ECONOMIC FLUCTUATIONS OR IN THE EVENT OF A DISASTER. AT THE CORE OF OUR MISSION IS OUR ABILITY TO RESEARCH AND TREAT LIFE-THREATENING CHILDHOOD DISEASES FOR THE PATIENTS WHO COME THROUGH OUR DOORS TODAY AND IN THE FUTURE. OUR PIONEERING RESEARCH CAN TAKE FIVE TO TEN YEARS OR MORE PER PROJECT TO COMPLETE AND COST MILLIONS. TREATMENTS FOR PEDIATRIC CANCER CAN LAST THREE YEARS OR MORE AND COST, ON AVERAGE, $425,000. WE ARE ALSO IN THE MIDST OF A MULTI-BILLION DOLLAR EXPANSION THAT WAS ANNOUNCED IN 2015. THIS PLAN INCLUDES NEW RESEARCH AND CLINICAL FACILITIES, HOUSING FOR MORE PATIENTS, AND AN AMBITIOUS GLOBAL PLAN WHERE WE AIM TO IMPACT 30% OF THE GLOBAL PEDIATRIC CANCER BURDEN. PART X, LINE 2: AS OF JUNE 30, 2017, ALSAC HAD NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS UNDER ASC TOPIC 740, INCOME TAXES, REQUIRING ADJUSTMENTS TO ITS FINANCIAL STATEMENTS. IN THE EVENT ALSAC WERE TO RECOGNIZE INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IT WOULD BE RECOGNIZED IN THE FINANCIAL STATEMENTS AS A GENERAL EXPENSE. GENERALLY, TAX YEARS ENDING IN 2014 THROUGH 2017 ARE OPEN TO EXAMINATION BY THE FEDERAL AND STATE TAXING AUTHORITIES, RESPECTIVELY. THERE ARE NO INCOME TAX EXAMINATIONS CURRENTLY IN PROCESS. PART XI, LINE 4B - OTHER ADJUSTMENTS: DIRECT GAMING EXPENSES -7,994,869. PART XII, LINE 2D - OTHER ADJUSTMENTS: DIRECT GAMING EXPENSES 7,994,869. DIRECT GAMING EXPENSES INDENTIFIED ABOVE REFER TO THE ST. JUDE DREAM HOME GIVEAWAYS. CENTRAL AMERICA & THE CARIBBEAN INVESTMENTS 1092193000 EUROPE (INCLUDING ICELAND AND GREENLAND) INVESTMENTS 60368000 EAST ASIA AND THE PACIFIC INVESTMENTS 28644000 NORTH AMERICA INVESTMENTS 6902000 SOUTH ASIA INVESTMENTS 3758000 RUSSIA AND NEIGHBORING STATES INVESTMENTS 2624000 SOUTH AMERICA INVESTMENTS 2174000 0 0 0 0 0 0 1196663000 0 1196663000 1 0 1 1 1 0 X X X X X X 1 INFOCISION MANAGEMENT CORP 325 SPRINGSIDE DR AKRON OH 44333 FUNDRAISING SOLICITOR 0 5212679 4974534 238145 MDS COMMUNICATIONS CORP 545 W JUANITA AVE MESA AZ 85210 FUNDRAISING SOLICITOR 0 2019823 1033923 985900 EAGLECOM INC 2300 YONGE STREET SUITE 1700 BOX TORONTO, ON CA M4P 1E4 FUNDRAISING COUNSEL 0 0 2392750 -2392750 PMX AGENCY INC 5 HANOVER SQUARE NEW YORK NY 10004 FUNDRAISING COUNSEL 0 0 1318469 -1318469 MINDSET DIRECT 1700 N JEFFERSON ST ARLINGTON VA 22205 FUNDRAISING COUNSEL 0 0 376801 -376801 RUSS REID COMPANY INC 2 N LAKE AVE SUITE 600 PASADENA CA 91101 FUNDRAISING COUNSEL 0 0 349985 -349985 NNE MARKETING LLC 1666 MASSACHUSETTS AVE STE 14 LEXINGTON MA 02420 FUNDRAISING COUNSEL 0 0 210000 -210000 ELEVENTY MARKETING GROUP 453 S HIGH ST SUITE 101 AKRON OH 44311 FUNDRAISING COUNSEL 0 0 91729 -91729 7232502 10748191 -3515689 AK AL AR CA CO CT DC FL GA HI IL KS KY LA MA MD ME MI MN MO MS NC ND NH NJ NM NV NY OH OK OR PA RI SC TN UT VA WA WI WV GALA 1160054 293702 866352 5890 9387 38127 16580 31313 GALA 1156945 334537 822408 125 33535 85006 46049 44314 151 22903942 7453361 15450581 98095 1038034 2031257 1007018 1183767 25220941 8081600 17139341 104110 1080956 2154390 1069647 1259394 5668497 11470844 27071844 4345891 10971 3638007 1 0.19000 27071844 4345891 10971 3638007 7994869 19076975 CA GA ID IL KS KY LA MA MN MO MS NC NV NY OH OK RI TN TX VA 1 0 1 0 0.05000 0.95000 JEFFREY T PEARSON 501 ST JUDE PLACE MEMPHIS TN 38105 0 BRIAN DOYLE 158581 MANAGES THE PLANNING AND EXECUTION OVERSIGHT OF RAFFLE ACTIVITIES X 1 5225538 1 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS PLACE MEMPHIS TN 38105 620646012 501(C)(3) 663714692 0 SUPPORT FOR OPERATIONAL AND CAPITAL BUDGET NEEDS 1 0 PART I, LINE 2: THE SOLE RECIPIENT OF GRANTS AND SUPPORT IS ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. ALSAC IS THE FUNDRAISING AND AWARENESS ORGANIZATION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL. ALSAC EXISTS SOLELY TO BUILD AWARENESS AND RAISE THE FUNDS NECESSARY TO OPERATE AND MAINTAIN ST. JUDE. IT COSTS NEARLY $1 BILLION TO OPERATE ST. JUDE, AND MORE THAN 75 PERCENT OF ST. JUDE'S OPERATING BUDGET IS COVERED BY GENEROUS DONORS WHO SUPPORT THE LIFE-SAVING MISSION OF ST. JUDE. X X 1 1 X X X X X X 0 1 0 0 0 0 0 0 0 JAMES R DOWNING EX-OFFICIO DIRECTOR 0 910468 0 50000 0 79487 0 29150 0 18039 0 1087144 0 0 RICHARD C SHADYAC JR CEO & EX-OFFICIO DIRECTOR 769962 0 0 0 2322 0 79563 0 16796 0 868643 0 0 0 EMILY S GREER CHIEF ADMIN. OFFICER 453339 0 0 0 1242 0 66652 0 21508 0 542741 0 0 0 JEFFREY T PEARSON CHIEF FINANCIAL OFFICER 428260 0 0 0 1242 0 64461 0 23330 0 517293 0 0 0 EMILY CALLAHAN CHIEF MARKETING OFFICER 433601 0 0 0 486 0 57056 0 23252 0 514395 0 0 0 ROBERT MACHEN CHIEF INFORMATION OFFICER 419787 0 0 0 810 0 55908 0 20619 0 497124 0 0 0 ANURAG PANDIT CHIEF INVESTMENT OFFICER 404076 0 0 0 2322 0 45249 0 20291 0 471938 0 0 0 SARA HALL CHIEF LEGAL OFFICER 379846 0 0 0 810 0 53181 0 20414 0 454251 0 0 0 GEORGE SHADROUI CHIEF STRATEGY OFFICER 375789 0 0 0 2322 0 59914 0 9284 0 447309 0 0 0 PART I, LINE 1A TRAVEL FOR COMPANIONS: PAYMENT FOR COMPANION TRIPS IS AN INFREQUENT PRACTICE. IT IS LIMITED TO INSTANCES WHERE IT IS NECESSARY, APPROPRIATE AND EXPECTED FOR THE CEO'S SPOUSE TO PARTICIPATE IN HOSTING AND REPRESENTING ALSAC. HEALTH OR SOCIAL CLUB DUES: A SOCIAL CLUB MEMBERSHIP WAS MADE AVAILABLE TO THE CEO BUT LIMITED TO BUSINESS PURPOSES IN ACCORDANCE WITH A WRITTEN POLICY DIRECTIVE. PART I, LINE 4B: THE ORGANIZATION ESTABLISHED A NON-QUALIFIED DEFERRED COMPENSATION PLAN PURSUANT TO CODE SECTION 457(F) OF THE INTERNAL REVENUE CODE. THE PLAN AMOUNTS ARE SUBJECT TO SUBSTANTIAL FUTURE SERVICE REQUIREMENTS TO THE ORGANIZATION AND ARE SUBJECT TO SUBSTANTIAL RISK OF FORFEITURE. NO PAYMENTS WERE MADE TO LISTED PERSONS IN PART VII UNDER THE NON-QUALIFIED DEFERRED COMPENSATION PLAN DURING THE YEAR. X 54 X 23 X 3 X 952 16683289 COST OR SELLING PRICE X 41 X 4 X 5 X 125 X PRIZE PACKAGES 483 0 X GIFT CARDS 115 0 X OTHER PRIZES 601 0 1 0 1 0 PART I, COLUMN (B): THE NUMBERS IN COLUMN (B) REFER TO THE NUMBER OF CONTRIBUTIONS. PART I, LINE 33: RECEIPTS FOR LINES 1, 6, 7, 15, 16, 17, 18, 25, 26 AND 27 ARE REPORTED ON FORM 990, PART VIII, LINE 1F, LINE 8A OR LINE 9A. FORM 990, PART III, LINE 4A: WHEN ST. JUDE OPENED ITS DOORS IN 1962, THE SURVIVAL RATE FOR CHILDHOOD CANCER WAS LESS THAN 20%. SINCE THAT TIME, TREATMENTS INVENTED AT ST. JUDE HAVE HELPED PUSH OVERALL SURVIVAL RATES FOR CHILDHOOD CANCERS TO MORE THAN 80 PERCENT TODAY. ST. JUDE IS WORKING TO DRIVE THE OVERALL SURVIVAL RATE FOR CHILDHOOD CANCER TO 90 PERCENT, AND WE WON'T STOP UNTIL NO CHILD DIES FROM CANCER. TODAY, ST. JUDE IS LEADING THE WAY THE WORLD UNDERSTANDS, TREATS AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATENING DISEASES. ST. JUDE HAS LED AN UNPRECEDENTED EFFORT TO SEQUENCE THE PEDIATRIC CANCER GENOME AND TO IDENTIFY THE GENETIC CHANGES THAT GIVE RISE TO SOME OF THE WORLD'S DEADLIEST CHILDHOOD CANCERS, AND CONTINUES PIONEERING WORK IN THE AREAS OF GENOMICS. AND ST. JUDE CONTINUES TO UPHOLD ITS PROMISE OF CONDUCTING PIONEERING RESEARCH AND PROVIDING EXCEPTIONAL PATIENT CARE, ALL WHILE ENSURING THAT NO FAMILY EVER RECEIVES A BILL FROM ST. JUDE FOR TREATMENT, TRAVEL, HOUSING OR FOOD - BECAUSE ALL A FAMILY SHOULD WORRY ABOUT IS HELPING THEIR CHILD LIVE. ST. JUDE ALSO MAINTAINS A SCHOOL PROGRAM TO PROVIDE OPPORTUNITIES FOR PATIENTS TO CONTINUE THEIR NORMAL EDUCATIONAL ACTIVITIES AND TO PROVIDE RE-ENTRY SERVICES TO EASE THE TRANSITION BACK TO COMMUNITY SCHOOLS. ST. JUDE FREELY SHARES THE DISCOVERIES WE MAKE, AND EVERY CHILD SAVED AT ST. JUDE MEANS DOCTORS AND SCIENTISTS WORLDWIDE CAN USE THAT KNOWLEDGE TO SAVE THOUSANDS MORE CHILDREN. ST. JUDE IS THE FIRST AND ONLY NATIONAL CANCER INSTITUTE-DESIGNATED COMPREHENSIVE CANCER CENTER DEVOTED SOLELY TO CHILDREN. ST. JUDE IS WHERE DOCTORS OFTEN SEND THEIR TOUGHEST CASES, BECAUSE ST. JUDE HAS THE WORLD'S BEST SURVIVAL RATES FOR SOME OF THE MOST AGGRESSIVE FORMS OF CHILDHOOD CANCERS. ST. JUDE CREATES MORE CLINICAL TRIALS FOR CANCER THAN ANY OTHER CHILDREN'S HOSPITAL AND TURNS LABORATORY DISCOVERIES INTO LIFESAVING TREATMENTS THAT BENEFIT PATIENTS EVERY DAY. ST. JUDE'S RESEARCHERS ARE PUBLISHED AND CITED MORE OFTEN IN HIGH IMPACT PUBLICATIONS THAN ANY OTHER PEDIATRIC ONCOLOGY INSTITUTION IN AMERICA. ST. JUDE HAS ACHIEVED THE HIGHEST SURVIVAL RATE IN THE WORLD FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), THE MOST COMMON CHILDHOOD CANCER. NINETY-FOUR PERCENT OF CHILDREN WITH ALL AT ST. JUDE SURVIVE, COMPARED TO THE NATIONAL SURVIVAL RATE OF 90%. AND IT WAS ST. JUDE'S GROUNDBREAKING DEVELOPMENT IN THE TREATMENT OF ALL THAT REVOLUTIONIZED LEUKEMIA THERAPY WORLDWIDE. IN ADDITION TO CHILDHOOD CANCER, ST. JUDE PLAYS A CRITICAL LEADERSHIP ROLE IN GROUNDBREAKING STUDIES ON SICKLE CELL DISEASE, INFECTIOUS DISEASES AND GENETIC DISORDERS. THESE EFFORTS ARE INSTRUMENTAL TO IMPROVING CARE FOR CHILDREN AROUND THE WORLD. ST. JUDE WAS THE FIRST INSTITUTION TO DEVELOP A CURE FOR SICKLE CELL DISEASE WITH A BONE MARROW TRANSPLANT AND HAS ONE OF THE LARGEST PEDIATRIC SICKLE CELL PROGRAMS IN THE COUNTRY. IN ADDITION, THE BRAIN TUMOR SCIENCE AND TECHNOLOGY AT ST. JUDE ARE AT THE CUTTING EDGE WORLDWIDE, AND ST. JUDE HAS THE LARGEST RESEARCH-BASED PEDIATRIC BRAIN TUMOR RESEARCH PROGRAM IN THE COUNTRY. ST. JUDE IS THE COORDINATING CENTER OF THE NATIONAL PEDIATRIC BRAIN TUMOR CONSORTIUM, WHICH RECEIVES FUNDING FROM THE NATIONAL CANCER INSTITUTE. AND ST. JUDE'S EFFORTS TO SAVE THE LIVES OF CANCER PATIENTS DON'T END WHEN TREATMENT STOPS. THE ST. JUDE AFTER COMPLETION OF THERAPY (ACT) PROGRAM IS THE LARGEST LONG-TERM, FOLLOW-UP CLINIC FOR PEDIATRIC CANCER PATIENTS IN THE UNITED STATES AND ST. JUDE DOES THIS AT NO COST TO THE PATIENTS. THE CLINIC HELPS PATIENTS STAY HEALTHY AFTER ACTIVE TREATMENT ENDS AND HAS BEEN A PROTOTYPE FOR OTHER LONGER TERM FOLLOW-UP PROGRAMS. FORMER ST. JUDE PATIENTS ALSO ARE PARTICIPATING IN THE ST. JUDE LIFE STUDY, DESIGNED TO HELP ADULT SURVIVORS OF CHILDHOOD CANCER LEARN ABOUT ISSUES THAT AFFECT THEIR HEALTH AS WELL AS WAYS TO STAY HEALTHY. AND ST. JUDE IS HOME TO THE CHILDHOOD CANCER SURVIVOR STUDY, A COLLABORATIVE STUDY AMONG 30 U.S. AND CANADIAN INSTITUTIONS THAT INCLUDES MORE THAN 20,000 CHILDHOOD CANCER SURVIVORS. FORM 990, PART V, LINE 4B (CONTINUED); THE FINANCIAL ACCOUNTS IN THE FOREIGN COUNTRIES LISTED ON FORM 990, PART V, LINE 4B (AND SCHEDULE O) ARE RELATED TO INVESTMENTS. NO FINANCIAL ACCOUNTS FOR OPERATIONAL PURPOSES WERE MAINTAINED IN FOREIGN COUNTRIES. FORM 990, PART VI, SECTION A, LINE 2 FAMILY RELATIONSHIP AMONG DIRECTORS: JOSEPH S. AYOUB, JR., ESQ. AND PAUL J. AYOUB, ESQ.; FREDERICK R. HARRIS AND FREDERICK R. HARRIS, JR., MD; GEORGE A. SIMON, II AND PAUL J. SIMON; ROBERT A. BREIT, MD AND JOSEPH G. SHAKER; JOSEPH C. SHAKER AND JOSEPH G. SHAKER; PAUL J. SIMON AND MICHAEL SIMON. FORM 990, PART VI, SECTION A, LINE 4 EFFECTIVE JUNE 24, 2017, ALSAC AMENDED ITS BYLAWS. THE SIGNIFICANT CHANGES ARE AS FOLLOWS: - BOARD MEMBERS ARE PERMITTED TO BE ELECTED AT ANY REGULARLY SCHEDULED BOARD MEETING; AND - THE AMENDMENT EXTENDS A NEW BOARD MEMBER'S INITIAL TERM TO TWO YEARS, FOLLOWED BY THREE-YEAR TERMS UNLESS THE MEMBERSHIP COMMITTEE RECOMMENDS A DIFFERENT TERM. FORM 990, PART VI, SECTION B, LINE 11B IN FEBRUARY OF EACH YEAR, THE AUDIT COMMITTEE AND OFFICERS OF THE BOARD ARE PROVIDED WITH A DRAFT COPY OF FORM 990 AND ALL REQUIRED SCHEDULES. THE AUDIT COMMITTEE MEETS WITH ITS TAX PREPARER TO REVIEW THE DRAFT FORM 990 BEFORE IT IS FILED WITH THE IRS. ADDITIONALLY, THE COMPENSATION COMMITTEE OF THE BOARD RECEIVES A DRAFT COPY OF THE COMPENSATION SECTIONS OF FORM 990 FOR REVIEW BEFORE IT IS FILED WITH THE IRS. EACH VOTING MEMBER OF THE BOARD RECEIVES A FINAL COPY OF FORM 990 WITH ALL REQUIRED SCHEDULES BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION MAINTAINS A CONFLICT OF INTEREST COMMITTEE OF THE BOARD OF DIRECTORS. IN ADDITION TO EDUCATION OF NEW BOARD MEMBERS ON THE CONFLICT OF INTEREST POLICY, THE ADMINISTRATOR TO THE BOARD/CHIEF GOVERNANCE OFFICER MONITORS CONFLICT MANAGEMENT PLANS (WHICH MAY INCLUDE CHANGING VENDORS, DIVESTITURE OF FINANCIAL INTERESTS, AND THE LIKE) TO ENSURE THEY ARE COMPLETED IN A TIMELY FASHION. UNDISCLOSED CONFLICTS ARE DISCOVERED, WHERE POSSIBLE, THROUGH THE ORGANIZATION'S CONTRACTING PROCESS. THIS IS TRUE FOR THE BOARD'S CONFLICT OF INTEREST POLICY AND FOR THE SEPARATE CONFLICT OF INTEREST POLICY APPLICABLE TO ALL ADMINISTRATION OF THE ORGANIZATION (POTENTIAL CONFLICTS OF THE ORGANIZATION ARE DISCUSSED AND RESOLVED AT A SENIOR-LEVEL CONFLICTS OF INTEREST COMMITTEE). POTENTIAL RESTRICTIONS RANGE FROM UNWINDING OR PROHIBITING A TRANSACTION, TO PREVENTING SOMEONE FROM PARTICIPATING IN A DELIBERATION, TO SIMPLE DISCLOSURE TO THE BOARD OF THE CONFLICTING INTEREST, DEPENDING ON THE FACTS AND CIRCUMSTANCES OF THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 TO ATTRACT THE BEST PROFESSIONALS AND EMPLOYEES OF ALL TYPES, COMPENSATION FOR OUR SENIOR EXECUTIVES IS DETERMINED BY A COMPENSATION COMMITTEE OF OUR BOARD MADE UP OF INDEPENDENT DIRECTORS ONLY WHO ARE ADVISED BY AN OUTSIDE, INDEPENDENT COMPENSATION EXPERT. OUR SALARIES FALL WITHIN THE 50-75 PERCENTILE OF THE MARKET RANGE FOR ORGANIZATIONS OF SIMILAR SIZE AND SHAPE. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 26: WE CONDUCT A NUMBER OF ACTIVITIES, WHICH JOINTLY BENEFIT OUR EDUCATION, TRAINING, AND COMMUNITY SERVICE PROGRAM OBJECTIVES, AS WELL AS FUNDRAISING AND GENERAL AND ADMINISTRATIVE ACTIVITIES. THE EDUCATIONAL INFORMATION SHARED WITHIN THESE ACTIVITIES SUPPORT OUR MISSION TO LEAD THE WAY THE WORLD UNDERSTANDS, TREATS AND DEFEATS CHILDHOOD CANCER AND OTHER LIFE-THREATING DISEASES AND INCLUDE OUR TELEVISION AND RADIO PROGRAMS AND COMMERCIALS, DIRECT MAIL PROGRAM, AND CERTAIN OTHER FUNDRAISING AND PUBLIC AWARENESS EVENTS. IN ACCORDANCE WITH THE FINANCIAL ACCOUNTINGS STANDARDS BOARD GUIDELINES, WE ALLOCATED A PORTION OF OUR FUNDRAISING EXPENSES TO PROGRAM SERVICE AND GENERAL AND ADMINISTRATIVE EXPENSES IN OUR COMBINED STATEMENTS OF FUNCTIONAL EXPENSES. ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS PLACE MEMPHIS TN 38105 620646012 HOSPITAL TN SECTION 501(C)(3) 3 N/A 0 0 1 0 0 0 0 0 0 0 1 0 1 0 1 0 1 1 0 0